Christina Arakaki
Optometrist · Fullerton, CANPI 1396238671
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $8,295 of the $10,103 with a category attached, or 82.1%. 27 manufacturers reported payments, led by Bausch & Lomb, A Division Of Bausch Health US, LLC at 28.3% of the total. Reporting peaked in 2019 at $3,260 and has fallen 74.6% since, to $829 in 2025. Among optometrist clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 272 payments — averaging $37.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bausch & Lomb, A Division Of Bausch Health US, LLC$3K
- AbbVie$1K
- Alcon$942
- Sun Pharmaceutical Industries Inc.$790
- Dompe US, Inc.$653
- Aerie Pharmaceuticals, Inc.$630
- plus $3K from 21 others
What the payments were for
- Travel & lodging$1,80818%
- Food & beverage$8,29582%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 30 | $2,861 |
| AbbVie(2 entities) | 30 | $1,168 |
| Alcon | 31 | $942 |
| Sun Pharmaceutical Industries Inc. | 41 | $790 |
| Dompe US, Inc. | 19 | $653 |
| Aerie Pharmaceuticals, Inc. | 30 | $630 |
| Glaukos Corporation | 12 | $456 |
| Bausch & Lomb Americas Inc. | 7 | $256 |
| Oyster Point Pharma, Inc. | 11 | $254 |
| Biotissue Holdings Inc. | 7 | $245 |
| Apellis Pharmaceuticals, Inc. | 2 | $241 |
| Tarsus Pharmaceuticals, Inc. | 4 | $199 |
| Shire North American Group Inc | 4 | $196 |
| Visioneering Technologies, Inc. | 2 | $196 |
| Rxsight Inc | 8 | $180 |
| Novartis | 3 | $175 |
| Kala Pharmaceuticals, Inc. | 8 | $173 |
| Amgen | 5 | $116 |
| Eyevance Pharmaceuticals LLC | 6 | $93 |
| Mallinckrodt Hospital Products Inc. | 3 | $81 |
| Genentech USA, Inc. | 2 | $51 |
| Johnson & Johnson Surgical Vision, Inc. | 2 | $43 |
| Optovue, Inc. | 1 | $29 |
| Carl Zeiss Meditec USA, Inc. | 1 | $26 |
| Ocular Therapeutix, Inc. | 1 | $23 |
| Harrow Eye, LLC | 1 | $14 |
| Sight Sciences, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ULTRA$1,751
- BIOTRUE$1,629
- Rhopressa$475
- Rocklatan$475
- BIOTRUE ONE DAY$247
- INFUSE$245
- Oxervate$245
- Syfovre$241
- CEQUA$235
- RESTASIS$224
- VUITY$224
- KXL System$134
- Photrexa$134
- RESTASIS MULTIDOSE$127
- ULTRA MULTIFOCAL TORIC$125
- XDEMVY$125
- LUMIGAN$124
- COMBIGAN$124
- EYSUVIS$124
- SIMBRINZA$119
How this compares
$10,103 in reported general payments places this provider in the 95th percentile of 6,778 optometrist providers in California.
Other optometrist in Fullerton
- Rachelle LinFullerton$43K
- William RidderFullerton$40K
- Steve YoelinNewport Beach$4.1M
- Matthew GellerSpring Valley$3.5M
- Melissa EricksonDavis$522K
- Omid KhodaiLake Forest$499K
- Jason TuSan Diego$351K
- Scott SchachterPismo Beach$312K
- Alicia LauSan Diego$300K
- Vin DangBakersfield$284K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.